Today: 19 May 2026
Boeing stock price dips as 777X engine issue and Dreamliner alert collide with airshow orders
3 February 2026
2 mins read

Boeing stock price dips as 777X engine issue and Dreamliner alert collide with airshow orders

New York, Feb 3, 2026, 14:30 ET — Regular session

Boeing (NYSE:BA) shares slipped roughly 0.9% to $230.90 in Tuesday’s afternoon session, after earlier hitting a high of $238.80. The stock hovered close to its day low of $229.11.

The dip comes as investors digest a flood of aviation news from the Singapore Airshow, where demand is climbing but supply chain bottlenecks are delaying deliveries. “As the aviation market continues to grow, there is a mismatch of demand-supply,” Jeffrey Lam, president of ST Engineering’s commercial aerospace division, said. Competitors like Airbus and China’s COMAC are also making moves; Jefferies analysts estimate this event has driven about 5% of global airshow orders since 2012. Reuters

Boeing’s stock moves as much on delivery speed and program risks as it does on new orders. Even a minor technical glitch can overshadow a modest order win, at least initially.

GE Aerospace said Monday it’s investigating a possible durability problem with the GE9X engine used on Boeing’s 777X, but stressed it’s too soon to know the full impact. Bloomberg News reported the issue involves an engine seal. Boeing CEO Kelly Ortberg revealed the concern last week, yet the company still aims to begin deliveries in 2027. The 777X has already been delayed by six years, with Boeing taking more than $15 billion in charges on the program. Boeing declined to comment Monday.

Air India grounded a Boeing 787 Dreamliner on Monday after a pilot spotted a potential fault with the aircraft’s fuel control switch. Sources told Reuters the pilot raised the alarm after landing in Bengaluru, following a flight from London. The airline said it was working closely with Boeing “on a priority basis,” with Boeing confirming it is providing support. These switches, which manage fuel flow to the engines, are at the heart of the investigation into last year’s Air India Dreamliner crash that claimed 260 lives. Reuters

Regulators remain a key wildcard for Boeing’s production plans in the short term. FAA chief Bryan Bedford confirmed the agency is still reviewing Boeing’s bid to ramp up 737 MAX output from 42 to 47 planes per month.

At the airshow, Air Cambodia placed an order for 10 Boeing 737 MAX jets, with an option to buy 10 more, Boeing confirmed. Cambodia’s civil aviation minister, Mao Havannall, called the deal “a strong and positive signal” of closer ties with the United States during a news conference. Reuters noted the purchase is tied to talks aimed at reducing a U.S. tariff on Cambodian goods, scaling back from a threatened 49% to 19%. Reuters

Air Cambodia CEO Dr. David Zhan called the 737-8 “the ideal combination of range, capacity and fuel efficiency” as the airline gears up for its next growth stage. Boeing sales exec Brad McMullen said the company is “proud to welcome” Air Cambodia as a new 737 MAX customer, noting this will be the first Boeing plane flown by a Cambodian carrier. MediaRoom

Boeing also revealed a setback in its defense efforts in Asia. The company has stopped building F-15 fighter jets for Indonesia, ending what it had once promoted as a signature deal to boost Jakarta’s military. “It is no longer an active campaign for us,” Bernd Peters said, referring to the 2023 agreement for 24 F-15EX jets, which still required U.S. government approval. Reuters

Boeing shares fell amid a broader market downturn, as Wall Street struggled Tuesday. Losses in software and cloud sectors triggered a more extensive selloff.

Near-term risks center on execution hiccups: a 777X engine seal review, increased focus on a 787 cockpit control, and potential delays in raising production caps could all shift delivery schedules. That’s typically when the stock starts to wobble.

The Singapore Airshow continues until Feb. 8. Traders are keeping an eye out for new customer deals and updates on production bottlenecks or shifts in delivery schedules.

Stock Market Today

  • India IPO Fundraising Drops to Two-Year Low in Early 2026 with Uncertain Outlook for H2
    May 19, 2026, 6:19 AM EDT. India's IPO fundraising has plunged to Rs 56,322 crore in the first five months of 2026, marking a sharp decline from Rs 82,678 crore in the same period last year and a two-year low, according to Primedatabase. Contributing factors include market volatility, geopolitical tensions, and cautious investor behavior amid global uncertainties. Notably, average subscription rates fell to roughly 2x in early 2026 from 38x in H2 2025, signaling weakened appetite. Despite a healthy pipeline with major listings from NSE and Jio Platforms expected in the second half, experts warn recovery will be cautious and selective. Institutional investors now favor profitable, scalable firms over aggressive growth models. The primary market slowdown contrasts with record 2025 fundraising and raises concerns about H2 momentum.

Latest articles

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

Hesai Up Premarket After Mercedes Lidar Win, Q1 Profit

19 May 2026
Hesai Group shares rose 2.68% to $22.60 in U.S. premarket trading after reporting a first-quarter profit and confirming it will supply lidar sensors for Mercedes-Benz Level 3 autonomous models. The company shipped 471,723 lidar units, up 140.9% year-on-year, and posted revenue of RMB680.6 million ($98.7 million). Net income reached RMB18.3 million, reversing a loss from a year earlier.
Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.

Popular

Dominion Energy Shares Move After NextEra’s $67 Billion Plan Seen as AI Power Play

Dominion Energy Shares Move After NextEra’s $67 Billion Plan Seen as AI Power Play

19 May 2026
NextEra Energy agreed to acquire Dominion Energy in a $66.8 billion all-stock deal, sending Dominion shares up 9.4% to $67.56 while NextEra fell 4.6%. Dominion holders would get 0.8138 NextEra share per Dominion share and a $360 million cash payment. The deal requires multiple regulatory approvals. Dominion’s Coastal Virginia Offshore Wind project remains a focus after cutting costs to $11.4 billion.
Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers
Previous Story

Thomson Reuters stock tumbles after National Bank target cut, as AI fears hit legal-data peers

Qualcomm stock tumbles ahead of earnings as investors weigh analyst note, key executive exit
Next Story

Qualcomm stock tumbles ahead of earnings as investors weigh analyst note, key executive exit

Go toTop